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Abstract: Mucosa-associated lymphoid tissue (MALT) lymphoma
arising in the thymus is extremely rare and little is known regarding
its clinicopathological features. This study examined the clinico-
pathological features of nine cases of thymic MALT lymphoma.
Most patients had autoimmune disease or hyperglobulinemia, and
they also had cysts in the tumors. Both increased serum autoanti-
body levels and polyclonal serum immunoglobulin levels remained
essentially unchanged after total thymectomy in all patients. Thymic
MALT lymphoma needs to be included in the differential diagnosis
in Asian patients with a cystic thymic mass accompanied by auto-
immune disease or hyperglobulinemia.
Key Words: MALT lymphoma, Thymus, Autoimmune disease,
Hyperglobulinemia.
(J Thorac Oncol. 2010;5: 117–121)
Extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) accounts for approx-
imately 7 to 8% of all B-cell lymphomas, and the gastroin-
testinal tract is the most common site, accounting for 50% of
all cases. Other common sites include the lung (14%), head
and neck (14%), ocular adnexae (12%), skin (11%), thyroid
(4%), and breast (4%).1 Hodgkins disease, lymphoblastic
lymphoma, and large cell lymphoma of B-cell origin arise in
the thymus, whereas MALT lymphoma of the thymus is
extremely rare.2 We encountered nine cases of MALT lym-
phoma arising in the thymus and reviewed their clinicopath-
ological features in this report.
PATIENTS AND METHODS
Tissue and Clinical Data
From the files of the Division of Thoracic and Visceral
Organ Surgery, Gunma University Graduate School of Med-
icine and Division of Thoracic Surgery, National Cancer
Center Hospital East, nine patients with thymic MALT lym-
phoma were identified. Four of these cases have been re-
ported previously.3–5 All specimens were obtained at initial
presentation and were reviewed by a pathologist. All tissue
samples were fixed in 10% buffered formalin and embedded
in paraffin. Tissue sections cut at 3 m were prepared and
stained with hematoxylin and eosin (H&E). Medical records
were reviewed to collect data on patient history, symptoms,
laboratory data, and type of treatments. Follow-up informa-
tion was obtained from clinical records and attending physi-
cians. For the reported cases included in this series, the
follow-up information was updated. Disease stage was as-
signed using an adaptation of the Ann Arbor staging system
for extranodal lymphomas.
RESULTS
Clinical Findings
The clinical findings of the nine patients are summa-
rized in the first nine lines of Table 1. All patients were
Japanese. Three patients were men and six were women
(male:female  1:2). Their ages ranged from 30 to 75 years
(mean, 58 years; median, 63 years). Eight patients were
asymptomatic, and their tumors were detected incidentally on
chest radiography at an annual health checkup or during
follow-up studies for other diseases. One patient had back
pain caused by the tumor. Cases 1, 7, and 8 had rheumatoid
arthritis, and cases 5, 8, and 9 had Sjo¨gren syndrome. Al-
though the remaining three patients did not have autoimmune
disease clinically, they showed serological findings sugges-
tive of autoimmune disease. Patient 9 had concurrent MALT
lymphomas in the lungs, which were discovered simulta-
neously. Physical examination did not reveal lymphadenop-
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athy or splenomegaly. The laboratory findings within 2 weeks
before and after total thymectomy are shown in Table 2. Nine
patients were seropositive for rheumatoid factor both before
and after surgery, except for case 3, who became seropositive
only after surgery. Eight patients were seropositive for anti-
nuclear antibody both before and after surgery. All patients
showed hypergammaglobulinemia: serum Immunoglobulon
G (IgG), IgA, and IgM levels were increased in six, five, and
five patients, respectively. Anti-SS-A antibody was detected
in seven patients and anti-SS-B antibody in four patients.
Eight patients had stage I disease and one had stage IV
disease. All patients underwent total thymectomy and only
patient 9 received radiotherapy. Both the increased serum
autoantibody levels and polyclonal increases in the serum Igs
TABLE 1. Summary of Clinicopathological Data of Primary Thymic MALT Lymphoma
Case
No. Nationality Age Sex Symptoms Autoimmunity
Hypergloblinemia
(Increased
Ig Type) Treatments Outcome
Macroscopic
Cysts
Microscopic
Cysts References
1 Japanese 55 F Back pain RA NA S NED No Yes 3
2 Japanese 63 F Asymptomatic Yesa P (IgG,A) S NED Yes Yes 4
3 Japanese 75 M Asymptomatic Yesa P (IgG, IgA) S NED Yes Yes 5
4 Japanese 30 F Asymptomatic Yesa P (IgG, IgM) S NED Yes Yes 5
5 Japanese 67 F Asymptomatic SjS P (IgG, IgM) S NED Yes Yes New case
6 Japanese 65 M Asymptomatic No M (IgM) S NED Yes Yes New case
7 Japanese 65 M Asymptomatic RA M(IgA) S NED Yes Yes New case
8 Japanese 55 F Asymptomatic RA,SjS P(IgG,M) S NED Yes Yes New case
9 Japanese 49 F Asymptomatic SjS P(IgG, IgA, IgM) S,RTx NED Yes Yes New case
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
10 Chinese 55 F Asymptomatic Yesa M (IgA) S,CTx NED Yes Yes 13
11 Japanese 59 F Chest pain SjS P (IgG,A,M) S,RTx NED Yes Yes 14
12 NA 52 M Asymptomatic No(but with
skin lesion)
NA S AWD Yes Yes 9
13 Japanese 64 F Back pain No No S NED No Yes 15
14 NA 72 F Chest painb No NA S NA Yes Yes 8
15 Japanese 61 M Asymptomatic SjS M (IgA) S,RTx Lost Yes Yes 16
16 Japanese 75 F Asymptomatic SjS M (IgA) S,RTx NED No Yes 16
17 NA 63 F Asymptomaticc Yesa Polyclonal S NED Yes Yes 10
18 Japanese 36 F Asymptomatic SjS P (IgG,A,M) S,CTx DOC No Yes 17
19 NA 56 F NA RA,SjS NA NA NA NA Yes 18
20 NA 45 M NA Scleroderma NA NA NA NA Yes 18
21 Japanese 47 F Asymptomatic SjS M (IgA) CTx,RTx AWD Yes Yes 19
22 Japanese 47 F Asymptomatic SjS P (IgG,A) S,RTx NED Yes Yes 7
23 Japanese 46 F Asymptomatic SjS No S,CTx NED Yes Yes 7
24 Japanese 67 M Asymptomatic No No CTx,RTx DOD No Yes 7
25 Chinese 42 F Asymptomatic No NA S Lost Yes Yes 7
26 Chinese 57 M Short breath No No CTx NED NA Yes 7
27 Chinese 45 F Hemoptysis SjS M (IgA) CTx,RTx NED NA Yes 7
28 NA 54 F Asymptomatic SjS NA S NED NA NA 12
29 NA 36 F Asymptomatic Childhood
Lupus
M (IgG) S, RTx AWD NA NA 12
30 NA 68 M Asymptomatic No NA S NA NA NA 12
31 Japanese 46 F Asymptomatic SjS No S NED Yes Yesd 20
32 Korean 43 F Asymptomatic RA,SjS No S NA No Yes 11
33 Caucasian 40 F Asymptomatic SjS M(IgA) S AWD NA Yes 21
34 Japanese 66 F Asymptomatic SjS NA S NED Yes Yes 22
35 Japanese 55 F Asymptomatic SjS NA S NED Yes Yes 22
36 Japanese 62 F Asymptomatic SjS NA S NED Yes Yes 22
37 Japanese 34 F Asymptomatic SjS NA S, CTx NA Yes NA 23
a Yes, probable autoimmune disease as suggested by serological findings.
b Chest pain proved to be due to acute myocardial infarction.
c Weight loss, cold hands, night sweats, dry eyes, and a dry mouth.
d Yes, recognized in Figure 3 of the literature.
SjS, Sjögren’s syndrome; RA, rheumatoid arthritis; NA, not available; CTx, chemotherapy; RTx, radiotherapy; S, surgery; NED, no evidence of disease; AWD, alive with disease;
DOD, death of disease; DOC, death of other causes; MALT, mucosa-associated lymphoid tissue.
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remained essentially unchanged after the total thymectomy
(Table 2). In cases 5 and 6, the serum Ig and autoantibody
levels remain increased 5 years after the thymectomy. To
date, all patients are well, without signs of recurrence.
Radiologic Findings and Gross Appearance
Computed tomography and magnetic resonance imag-
ing (MRI) of the chest showed a cystic thymic mass in all
eight of our cases with macroscopic cysts. On MRI, these
cysts were of increased signal intensity compared with cere-
brospinal fluid on T1-weighted images and of markedly
increased signal intensity (similar to that of cerebrospinal
fluid) on T2-weighted images (Figure 1A). All tumors were
confined to the thymus. Cross-sections revealed a solid tumor
with gray-white to light tan cut surfaces. Eight tumors con-
tained single or multiple macroscopic cysts (Figure 1B).
Histologic Findings
Histologically, all the tumors were separated from the
thymic fatty tissue by a thin fibrous capsule. Multiple cysts
and reactive lymph follicles with active germinal centers
were scattered within the tumors in all cases (Figure 2A). The
cyst walls were lined by flat epithelial cells. Morphologically,
these cysts were clearly distinguishable from the perivascular
spaces characteristic of thymoma. Epithelium-lined macro/
microscopic cysts were recognized in eight patients, whereas
microscopic cysts alone were observed in case 1.
All the tumors consisted mainly of dense centrocyte-
like cells and had a lobular structure. Centrocyte-like cells
invaded Hassall’s corpuscles (Figure 2B) and the cyst wall
epithelium (Figure 2C), forming lymphoepithelial lesions
(Figures 2B, C). In all cases, lymphoepithelial lesions and
plasma cell differentiation were observed. Plasma cells were
often found to aggregate around the vessels (Figure 2D).
Immunostaining for cytokeratin highlighted the lymphoepi-
thelial lesions that were formed predominantly by the ex-
panded Hassall’s corpuscles and epithelium lining the cysts.
The tumor cells were immunoreactive for CD20 but not for
CD3 or CD5.
API2-MALT1 Fusion Transcripts
Four samples (case1–4) were analyzed for expression
of the API2-MALT1 fusion transcripts by multiple reverse-
transcriptase polymerase chain reaction method described
previously.6 Case 2 sample showed no -actin reverse-tran-
scriptase polymerase chain reaction product, so we could not
analyze the transcripts. The API2-MALT1 fusion transcripts
were not detected in the other three cases.
DISCUSSION
MALT lymphoma arising in the thymus is extremely
rare. Including the current series, 37 cases have been reported
(Table 1).3–5,7–23 It is noteworthy that at least 28 (76%) of
these patients are Asians, and at least 30 (81%) of them had
autoimmune disease or hyperglobulinemia.4–23 All nine of
our patients were Japanese and were seropositive for rheu-
matoid factor or antinuclear antibody. Eight of them had
increased serum Ig levels, which remained almost unchanged
after total thymectomy. In two of the cases, the immunoglo-
bin and antibody abnormalities remain unchanged 5 years
after thymectomy. These data suggest that immunologic dis-
orders are strongly associated with thymic MALT lymphoma
tumorigenesis and that thymic MALT lymphoma did not
cause these disorders.
Expression analysis of API2-MALT1 fusion transcripts
in four of our patients detected no API2-MALT1 fusion
transcripts. Inagaki et al.7 investigated API2-MALT1 gene
TABLE 2. Laboratory Findings Before and After Thymectomy
Case 1
Pre/Post
Case 2
Pre/Post
Case 3
Pre/Post
Case 4
Pre/Post
Case 5
Pre/Post
Case 6
Pre/Post
Case 7
Pre/Post
Case 8
Pre/Post
Case 9
Pre/Post
Autoantibodies in serum
Rheumatoid factora / / / / / / / / /
Antinuclear antibodyb / / / / / / / / /
Anti-SS-A antibody / / / / / / / / /
Anti-SS-B antibody / / / / / / / / /
Serum protein
IgG (mg/dl)c / / / / / / / / /
IgA (mg/dl)d / / / / / / / / /
IgM (mg/dl)e / / / / / / / / /
ESRf /NA /NA /NA /NA /NA /NA /NA /NA /NA
CRPg 0.5/NA 0.1/NA 0.7/NA 0.1/NA 0.1/NA 0.1/NA 0.1/NA 0.4/NA 0.4/NA
sIL-2Rh 318/NA 433/NA 477/NA 252/205 NA NA 509 376/357 NA
Normal range: a 15 IU/ml.
b 40.
c 777–1762 mg/dl.
d 109–434 mg/dl.
e 30–188 mg/dl.
f Male 10 mm, female 15 mm.
g 0.5.
h 519 U/ml.
Pre, before total thymectomy; post, after total thymonectomy; ESR, erythrocyte sedimentation rate in the first hour; CRP, C-reactive protein; sIL-2R, soluble interleukin-2
receptor; , above normal range; , within normal range; NA, not available.
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fusion in 15 thymic MALT lymphoma cases, and found no
API2-MALT1 gene fusion in any of them, which was consis-
tent with our results. These findings suggest that oncogenic
events other than API2-MALT1 gene fusion are responsible
for thymic MALT lymphoma development.
Although macroscopic findings were not described in
eight previously reported cases, eight of our nine patients and
15 (75%) of the previous 20 cases had macroscopic cysts in
the tumor. Even in cases without macroscopic cysts, micro-
scopic cysts were identified in all cases, except for four
reported cases in which no microscopic findings were de-
scribed. Epithelium-lined cysts appear to be a distinct, con-
stant feature of thymic MALT lymphoma. As Chan24 specu-
lated, cyst formation may be related to the tendency toward
cystic transformation of medullary duct epithelium-derived
structures, including Hassall’s corpuscles, when the tumor
grows in the thymic gland. Yi et al.8 concluded that thymic
MALT lymphoma should be considered in the differential
diagnosis whenever a solid mass with cystic changes is
found. In our eight cases with macroscopic cysts, cysts were
observed as a solid thymic mass with cystic changes on
computed tomography and MRI. Cystic changes have been
observed in neoplastic thymic lesions, including thymoma,
non-Hodgkin lymphoma, Hodgkin disease, mediastinal sem-
inomas, and certain types of thymic carcinoma, and in non-
neoplastic thymic lesions.25 Cystic changes do not show
specific histologic features, and it is difficult to diagnose
these lesions definitively based on radiologic findings or
small biopsy specimens. In thymic MALT lymphomas, prev-
alence in Asians and a strong association with autoimmune
disease or hyperglobulinemia are distinctive clinically and
may be helpful in diagnosing the disease. On the basis of our
experience, we recommend the diagnostic flow chart for a
cystic thymic mass shown in Figure 3.
FIGURE 1. Magnetic resonance imaging (MRI) and gross
appearance of mucosa-associated lymphoid tissue (MALT)
thymic lymphoma. Case 4:, upper image, transverse T2-
weighted MRI showed a multilocular cyst in the right ante-
rior mediastinum. Lower image: the cut surface of the tumor
shows multiple follicular cysts.
FIGURE 2. Histologic appearance of thy-
mic mucosa-associated lymphoid tissue
(MALT) lymphoma. A, Reactive lymph folli-
cles with germinal center and cystic forma-
tions in the tumor. B, Lymphoepithelial le-
sion formed by a Hassall’s corpuscle
infiltrated by centrocyte-like (CCL) cells. C,
The epithelium lining the cyst is invaded by
CCL cells forming the lymphoepithelial le-
sion. The cyst contains eosinophilic material.
D, Mature plasma cells are found around
the vessels. HE, hematoxylin and eosin.
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In conclusion, thymic MALT lymphoma needs to be
included in the differential diagnosis in Asian patients with
thymic masses accompanied by cystic changes and autoim-
mune disease/hyperglobulinemia.
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FIGURE 3. Diagnostic flow chart for thymic mucosa-associ-
ated lymphoid tissue (MALT) lymphoma.
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